Global Market Report

Blood Preparation Market Report 2019-2029

Risk of infection transmission through transfused blood is the main factor which is hindering the growth of blood preparation market.

SKU: PHA0428 Category: Tag: Code: PHA0428Pages: 185
Clear
← Back to category Diagnostics

Description

Market Definition:
• Blood is a mixture of cellular elements, colloids and crystalloids. Different blood components have different relative density, sediment rate and size. Functional efficiency of each component is dependent on appropriate processing and proper storage.
• Blood is collected in a primary bag that contains anticoagulant-preservatives. Different components need different storage conditions and temperature requirements for therapeutic efficacy.

Market Overview and Trends
• South-east Asian countries such as Indonesia, India, Thailand and Myanmar are at highest risk of disease incidence. Strong product pipeline of anti-thrombotic and anticoagulant drugs coupled with rising awareness about blood donation in developing countries should propel industry growth.
• Blood and blood components market of global blood preparation market is expected to be growing due to increasing application of blood components and rising prevalence of bleeding disorders requiring blood transfusion.
• Organizations, such as the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), are taking initiatives for raising awareness levels via programs that aim to prevent thrombosis-associated complications in early stages
• As per NIH 2018 data, nearly 100,000 to 300,000 people in the U.S. die due to venous thrombosis annually. Anti-thrombotic and anticoagulants market is anticipated to witness high growth over the forecast timeframe owing to growing adoption of anti-thrombotic drugs to reduce mortality due to thrombosis.

Market Dynamics:

Factors Influencing the Market Growth:
• Growing demand for blood and its components in surgical procedures is expected to be a key factor driving the market.
• Growing geriatric population base and rising healthcare expenditures are likely to boost the market further.
• The introduction of novel technologies along with the increasing usage of plasma in pharmaceutical industry is further projected to contribute to the market growth.
• Various governments across the globe are focusing on increasing the number of blood donations through reimbursement policies, such as monetary incentives for donors. Further results in the growth of the global market

Factors Restraining the Market Growth:
• Risk of infection transmission through transfused blood is the main factor which is hindering the growth of blood preparation market.

Market Segmentation 2019-2029:
The Blood preparation market is segmented on the product type, application, and geography.

Product Type
• Whole Blood Market, 2019-2029
• Blood Components Market, 2019-2029
• Blood Derivatives Market, 2019-2029

Antithrombotic & Anticoagulants
• Platelet Aggregation Inhibitors Market, 2019-2029
• Fibrinolytics Market, 2019-2029
• Anticoagulants Market, 2019-2029

Application
• Thrombocytosis Market, 2019-2029
• Pulmonary Embolism Market, 2019-2029
• Renal Impairment Market, 2019-2029
• Angina Blood Vessel Complications Market, 2019-2029
• Others Market, 2019-2029

Geographic Breakdown
Focused regional forecasts and analysis explore the future opportunities:
• North America Market, 2019-2029
• Europe Market, 2019-2029
• Asia-Pacific Market, 2019-2029
• LAMEA Market, 2019-2029

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Blood preparation market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.
• In June 2017, Portola Pharmaceuticals, Inc. received FDA approval for the commercial launch of Bevyxxa, a novel oral anticoagulant drug

Major Market Players:
straZeneca PLC; Sanofi S.A.; LEO Pharma A/S; Bristol-Myers Squibb Company; Baxter International, Inc.; Pfizer, Inc.; Portola Pharmaceuticals, Inc.; and GlaxoSmithKline PLC

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

1. Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Stakeholders


2. Research Methodology
2.1 Research Data
2.1.1 Primary Data
2.1.2 Secondary Data
2.2 Market Size Estimation
2.3 Research Assumptions


3. Executive Summary

4. Industry Insights

5. Blood preparation Market - By Product Type
5.1 Whole Blood
5.2 Blood Components
5.3 Blood Derivatives


6. Blood preparation Market - By Antithrombotic & Anticoagulants Type
6.1 Platelet Aggregation Inhibitors
6.2 Fibrinolytics
6.3 Anticoagulants


7. Blood preparation Market - By Application
7.1 Thrombocytosis
7.2 Pulmonary Embolism
7.3 Renal Impairment
7.4 Angina Blood Vessel Complications
7.5 Others


8. Blood preparation Market - By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 UK
8.2.4 Rest of Europe
8.3 Asia-Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Rest of APAC
8.4 LAMEA
8.4.1 Latin America
8.4.2 Middle East
8.4.3 Africa


9. Competitive Landscape


10. Company Profiles
10.1 AstraZeneca PLC
10.2 Sanofi S.A.
10.3 LEO Pharma A/S
10.4 Bristol-Myers Squibb Company
10.5 Baxter International, Inc.
10.6 Pfizer, Inc.
10.7 Portola Pharmaceuticals, Inc.
10.8 GlaxoSmithKline PLC
10.9 Hikima Pharmaceuticals PLC


11. Appendix

List of Tables
Table 1 Global Blood Preparation Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 2 Global Blood Preparation Market Revenue Analysis & Forecast, By Antithrombotic & Anticoagulants Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 3 Global Blood Preparation Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 4 Global Blood Preparation Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR%), 2019-2029
Table 5 Global Blood Preparation Market Revenue Analysis & Forecast, By Region, (US$ Mn AGR%, CAGR%), 2019-2029
Table 6 North America Blood Preparation Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 7 North America Blood Preparation Market Revenue Analysis & Forecast, By Antithrombotic & Anticoagulants Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 8 North America Blood Preparation Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 9 North America Blood Preparation Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR%), 2019-2029
Table 10 U.S. Blood Preparation Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 11 U.S. Blood Preparation Market Revenue Analysis & Forecast, By Antithrombotic & Anticoagulants Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 12 U.S. Blood Preparation Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 13 U.S. Blood Preparation Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR%), 2019-2029
Table 14 Canada Blood Preparation Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 15 Canada Blood Preparation Market Revenue Analysis & Forecast, By Antithrombotic & Anticoagulants Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 16 Canada Blood Preparation Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 17 Canada Blood Preparation Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR%), 2019-2029
Table 18 Europe Blood Preparation Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 19 Europe Blood Preparation Market Revenue Analysis & Forecast, By Antithrombotic & Anticoagulants Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 20 Europe Blood Preparation Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 21 Europe Blood Preparation Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR%), 2019-2029
Table 22 Germany Blood Preparation Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 23 Germany Blood Preparation Market Revenue Analysis & Forecast, By Antithrombotic & Anticoagulants Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 24 Germany Blood Preparation Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 25 Germany Blood Preparation Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR%), 2019-2029
Table 26 France Blood Preparation Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 27 France Blood Preparation Market Revenue Analysis & Forecast, By Antithrombotic & Anticoagulants Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 28 France Blood Preparation Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 29 France Blood Preparation Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR%), 2019-2029
Table 30 UK Blood Preparation Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 31 UK Blood Preparation Market Revenue Analysis & Forecast, By Antithrombotic & Anticoagulants Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 32 UK Blood Preparation Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 33 UK Blood Preparation Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR%), 2019-2029
Table 34 Rest of Europe Blood Preparation Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 35 Rest of Europe Blood Preparation Market Revenue Analysis & Forecast, By Antithrombotic & Anticoagulants Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 36 Rest of Europe Blood Preparation Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 37 Rest of Europe Blood Preparation Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR%), 2019-2029
Table 38 Asia-Pacific Blood Preparation Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 39 Asia-Pacific Blood Preparation Market Revenue Analysis & Forecast, By Antithrombotic & Anticoagulants Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 40 Asia-Pacific Blood Preparation Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 41 Asia-Pacific Blood Preparation Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR%), 2019-2029
Table 42 Japan Blood Preparation Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 43 Japan Blood Preparation Market Revenue Analysis & Forecast, By Antithrombotic & Anticoagulants Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 44 Japan Blood Preparation Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 45 Japan Blood Preparation Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR%), 2019-2029
Table 46 China Blood Preparation Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 47 China Blood Preparation Market Revenue Analysis & Forecast, By Antithrombotic & Anticoagulants Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 48 China Blood Preparation Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 49 China Blood Preparation Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR%), 2019-2029
Table 50 India Blood Preparation Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 51 India Blood Preparation Market Revenue Analysis & Forecast, By Antithrombotic & Anticoagulants Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 52 India Blood Preparation Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 53 India Blood Preparation Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR%), 2019-2029
Table 54 Rest of APAC Blood Preparation Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 55 Rest of APAC Blood Preparation Market Revenue Analysis & Forecast, By Antithrombotic & Anticoagulants Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 56 Rest of APAC Blood Preparation Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 57 Rest of APAC Blood Preparation Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR%), 2019-2029
Table 58 LAMEA Blood Preparation Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 59 LAMEA Blood Preparation Market Revenue Analysis & Forecast, By Antithrombotic & Anticoagulants Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 60 LAMEA Blood Preparation Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 61 LAMEA Blood Preparation Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR%), 2019-2029
Table 62 Latin America Blood Preparation Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 63 Latin America Blood Preparation Market Revenue Analysis & Forecast, By Antithrombotic & Anticoagulants Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 64 Latin America Blood Preparation Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 65 Latin America Blood Preparation Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR%), 2019-2029
Table 66 Middle East Blood Preparation Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 67 Middle East Blood Preparation Market Revenue Analysis & Forecast, By Antithrombotic & Anticoagulants Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 68 Middle East Blood Preparation Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 69 Middle East Blood Preparation Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR%), 2019-2029
Table 70 Africa Blood Preparation Market Revenue Analysis & Forecast, By Product Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 71 Africa Blood Preparation Market Revenue Analysis & Forecast, By Antithrombotic & Anticoagulants Type, (US$ Mn AGR%, CAGR%), 2019-2029
Table 72 Africa Blood Preparation Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR%), 2019-2029
Table 73 Africa Blood Preparation Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR%), 2019-2029


List of Figures
Figure 1 Global Blood Preparation Market: Segmentation
Figure 2 Global Blood Preparation Market: Research Design
Figure 3 Global Blood Preparation Market: Drivers, Restraints, Opportunities, and Challenges
Figure 4 Global Blood Preparation Market: By Product Type
Figure 5 Global Blood Preparation Market: By Antithrombotic & Anticoagulants Type
Figure 6 Global Blood Preparation Market: By Application
Figure 7 Global Blood Preparation Market: By Technology
Figure 8 Global Blood Preparation Market: By Region
Figure 9 North America Blood Preparation Market: Market Snapshot
Figure 10 Europe Blood Preparation Market: Market Snapshot
Figure 11 Asia-Pacific Blood Preparation Market: Market Snapshot
Figure 12 LAMEA Blood Preparation Market: Market Snapshot
Figure 13 Market Share/Ranking: Financial Snapshot
Figure 14 AstraZeneca PLC: Financial Snapshot
Figure 15 Sanofi S.A.: Financial Snapshot
Figure 16 LEO Pharma A/S: Financial Snapshot
Figure 17 Bristol-Myers Squibb Company: Financial Snapshot
Figure 18 Baxter International, Inc.: Financial Snapshot
Figure 19 Pfizer, Inc.: Financial Snapshot
Figure 20 Portola Pharmaceuticals, Inc.: Financial Snapshot
Figure 21 GlaxoSmithKline PLC: Financial Snapshot
Figure 22 Hikima Pharmaceuticals PLC: Financial Snapshot

AstraZeneca PLC
Baxter International, Inc.
Bristol-Myers Squibb Company
GlaxoSmithKline PLC
Hikima Pharmaceuticals PLC
LEO Pharma A/S
Pfizer, Inc.
Portola Pharmaceuticals, Inc.
Sanofi S.A.